Theravance Biopharma (TBPH) Gross Profit (QoQ) (2013 - 2018)
Theravance Biopharma (TBPH) Gross Profit (QoQ) (2013 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2018 |
435.60% |
| Dec 31, 2017 |
-57.48% |
| Sep 30, 2017 |
53.38% |
| Jun 30, 2017 |
-14.95% |
| Mar 31, 2017 |
-44.52% |
| Dec 31, 2016 |
-75.75% |
| Sep 30, 2016 |
287.81% |
| Jun 30, 2016 |
-72.59% |
| Mar 31, 2016 |
2,447.98% |
| Dec 31, 2015 |
-93.16% |
| Sep 30, 2015 |
52.62% |
| Jun 30, 2015 |
-66.90% |
| Mar 31, 2015 |
1,219.62% |
| Dec 31, 2014 |
-129.98% |
| Sep 30, 2014 |
121.41% |
| Jun 30, 2014 |
256.01% |
| Mar 31, 2014 |
332.57% |
| Dec 31, 2013 |
629.17% |
| Sep 30, 2013 |
380.00% |
| Jun 30, 2013 |
-77.27% |
